MedTrace Logo

Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"

NCT03315403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 922

Last updated 2022-04-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the added diagnostic value of a quantitative polymerase chain reaction targeting the lytA gene in detecting pneumococci in patients with community-acquired pneumonia.

Conditions

  • Pneumonia, Pneumococcal
  • Community-acquired Pneumonia

Interventions

DIAGNOSTIC_TEST

LytA targeted quantitative polymerase chain reaction (qPCR)

LytA qPCR and cultures will be performed on samples of the upper respiratory tract (nasopahrynx, oropharynx, saliva, sputum if available)

Sponsors & Collaborators

  • Medical Center Alkmaar

    lead OTHER

Principal Investigators

  • Wim Boersma, MD. PhD. · Noordwest Ziekenhuisgroep

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-05
Primary Completion
2020-03-12
Completion
2020-03-12

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03315403 on ClinicalTrials.gov